Real-world impact of mepolizumab on pediatric and adolescent patients with severe asthma
Mepolizumab initiation was associated with significant reductions in asthma exacerbations, OCS and SABA use, and HCRU in children and adolescents with SA, demonstrating real-world clinical benefit.
Authors
- Annalise Hilts
- Michelle Hernández (ORCID: https://orcid.org/0000-0001-7445-6965)
- François Laliberté (ORCID: https://orcid.org/0000-0003-2601-6214)
- Tom Corbridge
- Arijita Deb (ORCID: https://orcid.org/0000-0002-4570-0364)
- Malena Mahendran
- Kaixin Zhang
Institutions
- University of North Carolina at Chapel Hill (US)
- Durham VA Medical Center (US)
- Providence Health & Services (US)
Publication Details
- Journal
- Journal of Allergy and Clinical Immunology Global
- Published
- 2025-12-20
- DOI
- https://doi.org/10.1016/j.jacig.2025.100638
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00